Mar. 26 at 8:31 PM
$PYNKF Q4 revenue up 303% YoY to
$293K. Net loss narrows 35% to
$3.4M. FDA PMA submission for B-Series OCT with AI – a pivotal milestone. Pivotal trial showed statistically significant reduction in residual cancer. Now in TN and NM hospitals. 9 S-Series placements in 2024 vs 3 in 2023. Cash
$6.2M. CEO: 'Just approaching the starting line.' Scalpel-sharp progress.
https://www.prnewswire.com/news-releases/perimeter-medical-imaging-ai-reports-fourth-quarter-and-full-year-2024-financial-results-and-provides-corporate-update-conference-callwebcast-today-at-5-pm-et-302412508.html